Collectively, these results suggest that tumor‐intrinsic I3A would enhance tumor immunogenicity, meanwhile IL4I1 overexpression increased tumor immunogenicity by increasing intracellular I3A production. This evidence concerns the gene IL4I1 and neoplasm.